-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Maravai Lifesciences Holdings, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2019 to 2024.
- Maravai Lifesciences Holdings, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2025 was -$4.29M, a 76.1% decline year-over-year.
- Maravai Lifesciences Holdings, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2025 was -$3.82M, a 101% decline year-over-year.
- Maravai Lifesciences Holdings, Inc. annual Income Tax Expense (Benefit) for 2024 was -$1.86M, a 100% decline from 2023.
- Maravai Lifesciences Holdings, Inc. annual Income Tax Expense (Benefit) for 2023 was $756M, a 1143% increase from 2022.
- Maravai Lifesciences Holdings, Inc. annual Income Tax Expense (Benefit) for 2022 was $60.8M, a 1.15% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)